Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Multi-Omics Profiling of Skin Biopsies of Patients with Sclerodermatous Graft-Vs-Host Disease Suggests Therapeutic Potential of Targeting Don't Eat Me Signals

Lu Cui, Cristabelle De Souza, Tristan Lerbs, Jessica Poyser, Clarissa Yu, Kerri Rieger, Sally Arai, Ryanne Brown, Judith A Shizuru, Antonia Maria Susanne Müller, Gerlinde Wernig

Blood (2022) 140 (Supplement 1): 272–273.

https://doi.org/10.1182/blood-2022-169789

Published: 2022

Journal Articles

Selective Targeting of Immune Modulatory Proteins to Mitigate Fibrosis and Inflammation in Sclerodermatous Graft-Vs-Host Disease

Lu Cui, Cristabelle De Souza, Tristan Lerbs, Jessica Poyser, Maryam Kooshesh, Atif Saleem, Kerri Rieger, Ryanne Brown, Bernice Kwong, Sebastian Fernandez-Pol, Sally Arai, Judith A Shizuru, Antonia MS Mueller, Gerlinde Wernig

Blood (2021) 138 (Supplement 1): 644.

https://doi.org/10.1182/blood-2021-151223

Published: 2021

Journal Articles

EXEL-8232, a Small Molecule JAK2 Inhibitor, Effectively Treats Thrombocytosis and Extramedullary Hematopoiesis in a Murine Model of Myeloproliferative Disease Induced by MPLW515L

Gerlinde Wernig, Michael G. Kharas, Dena S. Leeman, Rachel Okabe, Maricel Gozo, Mahnaz Paktinat, Erika Haydu, Brian Ball, Tulasi Khandan, Douglas O. Clary, D Gary Gilliland

Blood (2008) 112 (11): 3741.

https://doi.org/10.1182/blood.V112.11.3741.3741

Published: 2008

Journal Articles

High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia

Marc M. Loriaux, Ross L. Levine, Jeffrey W. Tyner, Stefan Fröhling, Claudia Scholl, Eric P. Stoffregen, Gerlinde Wernig, Heidi Erickson, Christopher A. Eide, Roland Berger, Olivier A. Bernard, James D. Griffin, Richard M. Stone, Benjamin Lee, Matthew Meyerson, Michael C. Heinrich, Michael W. Deininger, D. Gary Gilliland, Brian J. Druker

Blood (2008) 111 (9): 4788–4796.

https://doi.org/10.1182/blood-2007-07-101394

Published: 2008

Includes: Supplemental data

Journal Articles

The Jak2 V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes

Gerlinde Wernig, Jeffrey R. Gonneville, Brian J. Crowley, Margret S. Rodrigues, Mamatha M. Reddy, Heidi E. Hudon, Christoph Walz, Andreas Reiter, Klaus Podar, Yohan Royer, Stefan N. Constantinescu, Michael H. Tomasson, James D. Griffin, D. Gary Gilliland, Martin Sattler

Blood (2008) 111 (7): 3751–3759.

https://doi.org/10.1182/blood-2007-07-102186

Published: 2008

Journal Articles

Efficacy of TG101348, a Selective JAK2 Inhibitor, in Treatment of a Murine Model of JAK2V617F-Induced Polycythemia Vera.

Gerlinde Wernig, MD, Michael G. Kharas, PhD, Rachel Okabe, Sandra A. Moore, Dena S. Leeman, Dana E. Cullen, Maricel Gozo, Elizabeth P. McDowell, Ross L. Levine, John Doukas, Chi Ching Mak, Glenn Noronha, Michael Martin, Yon D. Ko, Benjamin H. Lee, Richard Soll, Ayalew Tefferi, John D. Hood, D. Gary Gilliland

Blood (2007) 110 (11): 556.

https://doi.org/10.1182/blood.V110.11.556.556

Published: 2007

Journal Articles

High-Throughput Sequence Analysis of the Tyrosine Kinome in Acute Myeloid Leukemia.

Marc Loriaux, Ross Levine, Jeffrey Tyner, Stephan Frohling, Claudia Scholl, Eric Stoffregen, Gerlinde Wernig, Heidi Erickson, Chris Eide, Roland Berger, Olivier Bernard, James Griffin, Richard Stone, Matthew Meyerson, Michael Heinrich, Michael Deininger, Gary Gilliland, Brian Druker

Blood (2007) 110 (11): 886.

https://doi.org/10.1182/blood.V110.11.886.886

Published: 2007

Journal Articles

JAK2 T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model

Thomas Mercher, Gerlinde Wernig, Sandra A. Moore, Ross L. Levine, Ting-Lei Gu, Stefan Fröhling, Dana Cullen, Roberto D. Polakiewicz, Olivier A. Bernard, Titus J. Boggon, Benjamin H. Lee, D. Gary Gilliland

Blood (2006) 108 (8): 2770–2779.

https://doi.org/10.1182/blood-2006-04-014712

Published: 2006

Includes: Supplemental data

Journal Articles

Expression of Jak2V617F causes a polycythemia vera–like disease with associated myelofibrosis in a murine bone marrow transplant model

Gerlinde Wernig, Thomas Mercher, Rachel Okabe, Ross L. Levine, Benjamin H. Lee, D. Gary Gilliland

Blood (2006) 107 (11): 4274–4281.

https://doi.org/10.1182/blood-2005-12-4824

Published: 2006

Includes: Supplemental data

NARROW

Multi-Omics Profiling of Skin Biopsies of Patients with Sclerodermatous Graft-Vs-Host Disease Suggests Therapeutic Potential of Targeting Don't Eat Me Signals

Selective Targeting of Immune Modulatory Proteins to Mitigate Fibrosis and Inflammation in Sclerodermatous Graft-Vs-Host Disease

EXEL-8232, a Small Molecule JAK2 Inhibitor, Effectively Treats Thrombocytosis and Extramedullary Hematopoiesis in a Murine Model of Myeloproliferative Disease Induced by MPLW515L

High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia

The Jak2 V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes

Efficacy of TG101348, a Selective JAK2 Inhibitor, in Treatment of a Murine Model of JAK2V617F-Induced Polycythemia Vera.

High-Throughput Sequence Analysis of the Tyrosine Kinome in Acute Myeloid Leukemia.

JAK2 T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model

Expression of Jak2V617F causes a polycythemia vera–like disease with associated myelofibrosis in a murine bone marrow transplant model

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only